Fig. 4From: Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer’s disease pathology and cognitive functionMediation effects of baseline AD pathology on the associations of CSF HGF with cognitive function in non-demented participants. Results of mediation analyses suggested that 45.59% of the total association of the CSF HGF with the decline in MMSE scores (A), 51.59% of the total association of the CSF HGF with the decline in ADNI-MEM scores (B), and 42.75% of the total association with the decline in ADNI-EF scores (C), were attributed to baseline Aβ42. Moreover, 94.59% of the total association of the CSF HGF with the decline in MMSE scores (D), 89.52% of the total association of the CSF HGF with the decline in ADNI-MEM scores (E), and 58.54% of the total association with the decline in ADNI-EF scores (F), were attributed to baseline pTau. In addition, 93.33% of the total association of the CSF HGF with the decline in MMSE scores (G), 89.16% of the total association of the CSF HGF with the decline in ADNI-MEM scores (H), and 53.92% of the total association with the decline in ADNI-EF scores (I), were attributed to baseline tTau. All models were adjusted for age, sex, years of education, and APOE4 statusBack to article page